BMS Secures Better HTA Result In Germany With Additional Data for Camzyos

 
• By Francesca Bruce

A revised benefit rating for BMS’ cardiomyopathy drug Camzyos will be good news for the product’s pricing in Germany.

Germany Heart
BMS' cardiomyopathy drug Camzyos gets upgraded benefit assessment rating in Germany • Source: Shutterstock

More from Europe

More from Geography